P

Inventor

WELLS JAMES A

US69 patents
⚠️ This page may combine multiple inventors who share the name “WELLS JAMES A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GENENTECH INC

38 patents
US7169901B2Jan 30, 2007

Anti-VEGF antibodies

GENENTECH INC160 citations99
US7060269B1Jun 13, 2006

Anti-VEGF antibodies

GENENTECH INC342 citations99
US6884879B1Apr 26, 2005

Anti-VEGF antibodies

GENENTECH INC623 citations99
US6451561B1Sep 17, 2002

Growth hormone variants

GENENTECH INC96 citations99
US6022711AFeb 8, 2000

Human growth hormone variants having enhanced affinity for human growth hormone receptor at site 1

GENENTECH INC100 citations99
US6013478AJan 11, 2000

Method for identifying active domains and amino acid residues in polypeptides and hormone variants

GENENTECH INC184 citations99
US5834598ANov 10, 1998

Human growth hormone variants

GENENTECH INC108 citations99
US5834250ANov 10, 1998

Method for identifying active domains and amino acid residues in polypeptides and hormone variants

GENENTECH INC432 citations99
US5780279AJul 14, 1998

Method of selection of proteolytic cleavage sites by directed evolution and phagemid display

GENENTECH INC198 citations99
US5580723ADec 3, 1996

Method for identifying active domains and amino acid residues in polypeptides and hormone variants

GENENTECH INC212 citations99
US5534617AJul 9, 1996

Human growth hormone variants having greater affinity for human growth hormone receptor at site 1

GENENTECH INC236 citations99
US7375193B2May 20, 2008

Anti-VEGF antibodies

GENENTECH INC62 citations98
US7365166B2Apr 29, 2008

Anti-VEGF antibodies

GENENTECH INC90 citations98
US7297334B2Nov 20, 2007

Anti-vegf antibodies

GENENTECH INC112 citations98
US6800740B1Oct 5, 2004

Variants of native growth hormones having non naturally occurring amino acid sequences or covalent modifications

GENENTECH INC77 citations98
US6428954B1Aug 6, 2002

Method for identifying active domains and amino acid residues in polypeptides and hormone variants

GENENTECH INC94 citations98
US6057292AMay 2, 2000

Method for inhibiting growth hormone action

GENENTECH INC198 citations98
US6040136AMar 21, 2000

Enrichment method for variant proteins with altered binding properties

GENENTECH INC139 citations98
US6013763AJan 11, 2000

Peptide variants of protein A

GENENTECH INC146 citations98
US5849535ADec 15, 1998

Human growth hormone variants

GENENTECH INC346 citations98
US5821047AOct 13, 1998

Monovalent phage display

GENENTECH INC1,243 citations98
US5750373AMay 12, 1998

Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants

GENENTECH INC1,868 citations98
US5688666ANov 18, 1997

Growth hormone variants with altered binding properties

GENENTECH INC154 citations98
US6057428AMay 2, 2000

Variants of vascular endothelial cell growth factor

GENENTECH INC90 citations97
US6780613B1Aug 24, 2004

Growth hormone variants

GENENTECH INC49 citations96
US6429186B1Aug 6, 2002

Ligand antagonists for treatment of breast cancer

GENENTECH INC77 citations96
US6271198B1Aug 7, 2001

Constrained helical peptides and methods of making same

GENENTECH INC103 citations96
US6143523ANov 7, 2000

Human growth hormone variants

GENENTECH INC84 citations96
US5955346ASep 21, 1999

Variants of human prolactin and human placeatal lactogen

GENENTECH INC54 citations96
US5854026ADec 29, 1998

Human growth hormone variant having enhanced affinity for human growth hormone receptor at site 1

GENENTECH INC78 citations96
US5846765ADec 8, 1998

Identification of novel substrates

GENENTECH INC79 citations96
US6387638B1May 14, 2002

Heregulin variants

GENENTECH INC51 citations95
US6197927B1Mar 6, 2001

Peptide variants of protein A

GENENTECH INC57 citations95
US6136563AOct 24, 2000

Human growth hormone variants comprising amino acid substitutions

GENENTECH INC67 citations95
US6004931ADec 21, 1999

Method for inhibiting growth hormone action

GENENTECH INC85 citations95
US5506107AApr 9, 1996

Selecting ligand agonists and antagonists

GENENTECH INC167 citations95
US6936440B1Aug 30, 2005

Selecting ligand agonists and antagonists

GENENTECH INC25 citations93
US5741664AApr 21, 1998

Subtilisin variants capable of cleaving substrates containing dibasic residues

GENENTECH INC21 citations92

GENENCOR INC

6 patents

GENENCOR INT

4 patents

TELEDYNE IND

1 patent

WELLS JAMES A

1 patent

Showing the top 50 of 69 patents by PatentIndex Score.